49 related articles for article (PubMed ID: 38556760)
1. Differential regulation of lung homeostasis and silicosis by the TAM receptors MerTk and Axl.
Guimarães-Pinto K; Leandro M; Corrêa A; Maia EP; Rodrigues L; da Costa ALA; Rafael Machado Ferreira J; Claudio-Etienne E; Siebenlist U; He J; Rigoni TDS; Ferreira TPT; Jannini-Sa YAP; Matos-Guedes HL; Costa-da-Silva AC; Lopes MF; Silva PMR; Kelsall BL; Filardy AA
Front Immunol; 2024; 15():1380628. PubMed ID: 38774866
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylserine and Tyro3-Axl-Mertk Receptor Tyrosine Kinase level detection in plasma and on plasma-derived extracellular vesicle surface in chronic lymphocytic leukemia.
Bay M; Seval GC; Coskun O; Gurman G; Erdas NO
Cell Biochem Funct; 2024 Jun; 42(4):e4035. PubMed ID: 38715180
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting of the functionally elusive TAM receptor family.
Miao YR; Rankin EB; Giaccia AJ
Nat Rev Drug Discov; 2024 Mar; 23(3):201-217. PubMed ID: 38092952
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Macrocyclic Pyrimidines as MerTK-Specific Inhibitors.
McIver AL; Zhang W; Liu Q; Jiang X; Stashko MA; Nichols J; Miley MJ; Norris-Drouin J; Machius M; DeRyckere D; Wood E; Graham DK; Earp HS; Kireev D; Frye SV; Wang X
ChemMedChem; 2017 Feb; 12(3):207-213. PubMed ID: 28032464
[TBL] [Abstract][Full Text] [Related]
5. Anexelekto (AXL) no more: microRNA-155 (miR-155) controls the "Uncontrolled" in SARS-CoV-2.
Papadopoulos KI; Papadopoulou A; Aw TC
Hum Cell; 2024 May; 37(3):582-592. PubMed ID: 38472734
[TBL] [Abstract][Full Text] [Related]
6. Data-Driven Construction of Antitumor Agents with Controlled Polypharmacology.
Da C; Zhang D; Stashko M; Vasileiadi E; Parker RE; Minson KA; Huey MG; Huelse JM; Hunter D; Gilbert TSK; Norris-Drouin J; Miley M; Herring LE; Graves LM; DeRyckere D; Earp HS; Graham DK; Frye SV; Wang X; Kireev D
J Am Chem Soc; 2019 Oct; 141(39):15700-15709. PubMed ID: 31497954
[TBL] [Abstract][Full Text] [Related]
7. Novel Substrate Prediction for the TAM Family of RTKs Using Phosphoproteomics and Structure-Based Modeling.
Widstrom NE; Andrianov GV; Heier JL; Heier C; Karanicolas J; Parker LL
ACS Chem Biol; 2024 Jan; 19(1):117-128. PubMed ID: 38159292
[TBL] [Abstract][Full Text] [Related]
8. MERTK and Fibrosis: A New Target for Therapy.
Pan Z; Eslam M
DNA Cell Biol; 2024 May; ():. PubMed ID: 38818793
[TBL] [Abstract][Full Text] [Related]
9. AXL in cancer: a modulator of drug resistance and therapeutic target.
Tang Y; Zang H; Wen Q; Fan S
J Exp Clin Cancer Res; 2023 Jun; 42(1):148. PubMed ID: 37328828
[TBL] [Abstract][Full Text] [Related]
10. Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment.
Myers KV; Amend SR; Pienta KJ
Mol Cancer; 2019 May; 18(1):94. PubMed ID: 31088471
[TBL] [Abstract][Full Text] [Related]
11. Discovery of Novel Macrocyclic MERTK/AXL Dual Inhibitors.
Kong D; Tian Q; Chen Z; Zheng H; Stashko MA; Yan D; Earp HS; Frye SV; DeRyckere D; Kireev D; Graham DK; Wang X
J Med Chem; 2024 Apr; 67(7):5866-5882. PubMed ID: 38556760
[TBL] [Abstract][Full Text] [Related]
12. MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents.
McDaniel NK; Cummings CT; Iida M; Hülse J; Pearson HE; Vasileiadi E; Parker RE; Orbuch RA; Ondracek OJ; Welke NB; Kang GH; Davies KD; Wang X; Frye SV; Earp HS; Harari PM; Kimple RJ; DeRyckere D; Graham DK; Wheeler DL
Mol Cancer Ther; 2018 Nov; 17(11):2297-2308. PubMed ID: 30093568
[TBL] [Abstract][Full Text] [Related]
13. TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma.
Holtzhausen A; Harris W; Ubil E; Hunter DM; Zhao J; Zhang Y; Zhang D; Liu Q; Wang X; Graham DK; Frye SV; Earp HS
Cancer Immunol Res; 2019 Oct; 7(10):1672-1686. PubMed ID: 31451482
[TBL] [Abstract][Full Text] [Related]
14. Tyro3, Axl, and Mertk receptors differentially participate in platelet activation and thrombus formation.
Zhou J; Yang A; Wang Y; Chen F; Zhao Z; Davra V; Suzuki-Inoue K; Ozaki Y; Birge RB; Lu Q; Wu Y
Cell Commun Signal; 2018 Dec; 16(1):98. PubMed ID: 30541554
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
